Search for: "Ronald Bruce Long" Results 101 - 103 of 103
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jan 2007, 6:14 pm
The present value of licensing revenues is unlikely to be a source of income that will substantially offset the cost of R&D by CIRM, taking into account the likely long lag between R&D funding and the realization of commercial therapies made possible with CIRM support. [read post]
9 Oct 2006, 5:12 pm
The Board found however that summary judgment regarding the gross backpay and other amounts for Ronald Hamilton, Matthew Aldrich, and Benjamin Adair was not appropriate because the Respondent set forth specific alternative figures for the pay rates of these three individuals and, accordingly raised a factual issue regarding their pay rates. [read post]